title: Stereotactic radiosurgery in the management of brain metastasis.
abstract: Metastatic disease to the brain occurs in a significant percentage of patients with cancer and can limit survival and worsen quality of life. Glucocorticoids and whole-brain radiation therapy (WBRT) have been the mainstay of intracranial treatments, while craniotomy for tumor resection has been the standard local therapy. In the last few years however, stereotactic radiosurgery (SRS) has emerged as an alternative form of local therapy. Studies completed over the past decade have helped to define the role of SRS. The authors review the evolution of the techniques used and the indications for SRS use to treat brain metastases. Stereotactic radiosurgery, compared with craniotomy, is a powerful local treatment modality especially useful for small, multiple, and deep metastases, and it is usually combined with WBRT for better regional control.
authors.affiliation: University of Pennsylvania Health System, Department of Neurosurgery, Philadelphia, Pennsylvania, USA.
authors.forename: Michael L
authors.initials: ML
authors.lastname: Smith
authors.forename: John Y K
authors.initials: JY
authors.lastname: Lee
mesh_terms: D001932:Brain Neoplasms / Q000556:secondary* / Q000601:surgery*; D003362:Cost-Benefit Analysis; D003399:Craniotomy / Q000009:adverse effects / Q000592:standards; D006801:Humans; D009362:Neoplasm Metastasis / Q000628:therapy*; D019635:Neurosurgical Procedures / Q000009:adverse effects / Q000592:standards; D018579:Patient Selection; D011183:Postoperative Complications / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control; D016634:Radiosurgery / Q000295:instrumentation / Q000379:methods* / Q000592:standards*; D011878:Radiotherapy / Q000009:adverse effects / Q000592:standards